| Intervention (n = 20) | Treatment as usual (n = 17) | Linear regression | ||||||
Variable | Baseline | 12 weeks | Change | Baseline | 12 weeks | Change | B | 95% CI | p |
Sex (female), n (%) | 12 (60.0) |
|
| 5 (29.4) |
|
|
|
| 0.20 |
Age, M (SD) | 44.3 (13.6) |
|
| 39.3 (12.1) |
|
|
|
| 0.25 |
Diagnoses, n (%) |
|
|
|
|
|
|
|
| 0.11 |
Psychotic spectrum disorder | 11(55.0) |
|
| 12 (70.6) |
|
|
|
|
|
Mood disorder | 7 (35) |
|
| 2 (11.8) |
|
|
|
|
|
Autism spectrum disorder |
|
|
| 2 (11.8) |
|
|
|
|
|
PTSD | 2 (10) |
|
|
|
|
|
|
|
|
Personality disorder |
|
|
| 1 (5.9) |
|
|
|
|
|
Medication use, n (%) |
|
|
|
|
|
|
|
|
|
Antipsychotics | 14 (70.0) |
|
| 15 (88.2) |
|
|
|
| 0.18 |
Antidepressants | 8 (40.0) |
|
| 7 (41.2) |
|
|
|
| 0.94 |
Benzodiazepines | 4 (20.0) |
|
| 6 (35.3) |
|
|
|
| 0.30 |
Mood stabilizers | 8 (40.0) |
|
| 1 (5.9) |
|
|
|
| 0.02 |
Non | 2 (10.0) |
|
| 1 (5.9) |
|
|
|
| 0.65 |
BSI, M |
|
|
|
|
|
|
|
|
|
Sum score | 1.73 | 1.72 | −0.01 | 1.89 | 1.95 | 0.06 | −0.24 | −0.65/0.16 | 0.23 |
Psychoticism | 1.75 | 1.68 | −0.07 | 1.94 | 2.12 | 0.18 | −0.54 | −1.12/0.04 | 0.07 |
Paranoid thoughts | 1.81 | 1.78 | −0.03 | 1.91 | 2.09 | 0.19 | −0.39 | −1.01/0.23 | 0.21 |
WHOQOL-BREF, M |
|
|
|
|
|
|
|
|
|
Domain I Physical health | 11.81 | 13.26 | 1.22 | 12.63 | 12.24 | -0.07 | 1.96 | 0.17/3.74 | 0.03 |
Domain II Psychological | 12.04 | 12.91 | 0.98 | 12.26 | 11.89 | -0.37 | 1.34 | −0.02/2.69 | 0.05 |
Domain III Social relationships | 12.98 | 13.12 | 0.08 | 11.89 | 11.89 | 0.00 | 0.11 | −2.03/2.25 | 0.92 |
Domain IV Environment | 15.29 | 15.43 | 0.04 | 15.00 | 14.50 | -0.17 | 0.64 | −0.47/1.75 | 0.25 |